Novo also disclosed that several manufacturers filed abbreviated new drug applications for generic versions of Ozempic, Wegovy and Rybelsus with Paragraph IV certifications
The findings of a large US real-world cohort (n= 18,000) study, published in 2024, show that patients on tirzepatide were significantly more likely to achieve 5 %, 10 % and 15 % weight loss compared with semaglutide (HR 1.76, 2.54, 3.24, respectively), with a 12-month mean weight difference of -6.9% 8
The primary mechanism involves stimulating insulin secretion in a glucose-dependent manner, suppressing glucagon release, and slowing gastric emptying
This enhanced efficacy is due to semaglutides unique ability to strongly bind to GLP-1 receptors, thereby effectively controlling appetite, slowing digestion, and helping patients feel full longer
Fast acting insulin aspart